aluates Reports

$ 0.0

Automative

Global Endometriosis Market Insights, Forecast to 2029

Published Date: August 2023

Report Code: QYRE-Auto-17Y8876

China Endometriosis Market Report Forecast 2021 2027

BUY CHAPTERS

Global Endometriosis Market Insights, Forecast to 2029

Code: QYRE-Auto-17Y8876

Report

August 2023

Pages:119

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Astrazeneca plc

Bayer HealthCare

Pfizer Inc

Addex Therapeutics

Astellas Pharma

Debiopharm

ElexoPharm GmbH

EndoCeutics

Euroscreen S.A.

Forendo Pharma

Kissei Pharmaceutical

Nippon Shinyaku

Takeda

Bayer

Endometriosis Market Size

The global Endometriosis market is projected to grow from US$ 1538.2 million in 2023 to US$ 1669.8 million by 2029, at a Compound Annual Growth Rate (CAGR) of 1.4% during the forecast period.

Endometriosis Market

Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel or tissue lining of the pelvic floor.

Rising incidences of endometriosis due to diagnostic improvements leading to early identification, environmental factors, and rising awareness is the key factor contributing to growth of the market. Global endometriosis market is expected to register a healthy growth, owing to rise in awareness amongst patients and physicians. In addition, considerable research efforts towards development of novel non hormonal drugs, diagnostic and surgical techniques coupled with substantial support in terms of funding has helped to further enhance the growth of this market. Therefore, huge unmet needs for curative treatment of endometriosis will serve this market as a potential opportunity. The growth in global endometriosis market will be primarily driven by emerging Asian economies, where the disease prevalence is almost 10% of the total female population of this region.

Report Includes:

This report presents an overview of global market for Endometriosis, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Endometriosis, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Endometriosis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Endometriosis sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Endometriosis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Endometriosis sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including AbbVie, AstraZeneca, Bayer HealthCare, Pfizer, Addex Therapeutics, Astellas Pharma, Debiopharm, ElexoPharm and EndoCeutics, etc.

Scope of Endometriosis Market Report

Report Metric	Details
Report Name	Endometriosis Market
Accounted market size in 2023	US$ 1538.2 million
Forecasted market size in 2029	US$ 1669.8 million
CAGR	1.4
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Gonadotropins Releasing Hormone Agonists Non-Steroidal Anti-Inflammatory Drugs Progestin Oral Contraceptive Pills
Segment by Application	Hospital Use Clinic Use Other
Segment by Region	US & Canada U.S. Canada China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia India Europe Germany France U.K. Italy Russia Middle East, Africa, Latin America Brazil Mexico Turkey Israel GCC Countries
By Company	AbbVie, AstraZeneca, Bayer HealthCare, Pfizer, Addex Therapeutics, Astellas Pharma, Debiopharm, ElexoPharm, EndoCeutics, Euroscreen, Forendo Pharma, Kissei Pharmaceutical, Neurocrine Biosciences, Nippon Shinyaku, Takeda, Bayer AG
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Endometriosis in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Endometriosis manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Endometriosis sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Endometriosis Market growing?

Ans: The Endometriosis Market witnessing a CAGR of 1.4 during the forecast period 2023-2029.

What is the Endometriosis Market size in 2029?

Ans: The global Endometriosis market is projected to grow from US$ 1538.2 million in 2023 to US$ 1669.8 million by 2029, at a Compound Annual Growth Rate (CAGR) of 1.4% during the forecast period.

Who are the main players in the Endometriosis Market report?

Ans: The main players in the Endometriosis Market are AbbVie, AstraZeneca, Bayer HealthCare, Pfizer, Addex Therapeutics, Astellas Pharma, Debiopharm, ElexoPharm, EndoCeutics, Euroscreen, Forendo Pharma, Kissei Pharmaceutical, Neurocrine Biosciences, Nippon Shinyaku, Takeda, Bayer AG

What are the Application segmentation covered in the Endometriosis Market report?

Ans: The Applications covered in the Endometriosis Market report are Hospital Use, Clinic Use, Other

What are the Type segmentation covered in the Endometriosis Market report?

Ans: The Types covered in the Endometriosis Market report are Gonadotropins Releasing Hormone Agonists, Non-Steroidal Anti-Inflammatory Drugs, Progestin, Oral Contraceptive Pills

1 Study Coverage

1.1 Endometriosis Product Introduction

1.2 Market by Type

1.2.1 Global Endometriosis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Gonadotropins Releasing Hormone Agonists

1.2.3 Non-Steroidal Anti-Inflammatory Drugs

1.2.4 Progestin

1.2.5 Oral Contraceptive Pills

1.3 Market by Application

1.3.1 Global Endometriosis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Hospital Use

1.3.3 Clinic Use

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Endometriosis Sales Estimates and Forecasts 2018-2029

2.2 Global Endometriosis Revenue by Region

2.2.1 Global Endometriosis Revenue by Region: 2018 VS 2022 VS 2029

2.2.2 Global Endometriosis Revenue by Region (2018-2023)

2.2.3 Global Endometriosis Revenue by Region (2024-2029)

2.2.4 Global Endometriosis Revenue Market Share by Region (2018-2029)

2.3 Global Endometriosis Sales Estimates and Forecasts 2018-2029

2.4 Global Endometriosis Sales by Region

2.4.1 Global Endometriosis Sales by Region: 2018 VS 2022 VS 2029

2.4.2 Global Endometriosis Sales by Region (2018-2023)

2.4.3 Global Endometriosis Sales by Region (2024-2029)

2.4.4 Global Endometriosis Sales Market Share by Region (2018-2029)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Endometriosis Sales by Manufacturers

3.1.1 Global Endometriosis Sales by Manufacturers (2018-2023)

3.1.2 Global Endometriosis Sales Market Share by Manufacturers (2018-2023)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Endometriosis in 2022

3.2 Global Endometriosis Revenue by Manufacturers

3.2.1 Global Endometriosis Revenue by Manufacturers (2018-2023)

3.2.2 Global Endometriosis Revenue Market Share by Manufacturers (2018-2023)

3.2.3 Global Top 10 and Top 5 Companies by Endometriosis Revenue in 2022

3.3 Global Key Players of Endometriosis, Industry Ranking, 2021 VS 2022 VS 2023

3.4 Global Endometriosis Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Endometriosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Endometriosis, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Endometriosis, Product Offered and Application

3.8 Global Key Manufacturers of Endometriosis, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Endometriosis Sales by Type

4.1.1 Global Endometriosis Historical Sales by Type (2018-2023)

4.1.2 Global Endometriosis Forecasted Sales by Type (2024-2029)

4.1.3 Global Endometriosis Sales Market Share by Type (2018-2029)

4.2 Global Endometriosis Revenue by Type

4.2.1 Global Endometriosis Historical Revenue by Type (2018-2023)

4.2.2 Global Endometriosis Forecasted Revenue by Type (2024-2029)

4.2.3 Global Endometriosis Revenue Market Share by Type (2018-2029)

4.3 Global Endometriosis Price by Type

4.3.1 Global Endometriosis Price by Type (2018-2023)

4.3.2 Global Endometriosis Price Forecast by Type (2024-2029)

5 Market Size by Application

5.1 Global Endometriosis Sales by Application

5.1.1 Global Endometriosis Historical Sales by Application (2018-2023)

5.1.2 Global Endometriosis Forecasted Sales by Application (2024-2029)

5.1.3 Global Endometriosis Sales Market Share by Application (2018-2029)

5.2 Global Endometriosis Revenue by Application

5.2.1 Global Endometriosis Historical Revenue by Application (2018-2023)

5.2.2 Global Endometriosis Forecasted Revenue by Application (2024-2029)

5.2.3 Global Endometriosis Revenue Market Share by Application (2018-2029)

5.3 Global Endometriosis Price by Application

5.3.1 Global Endometriosis Price by Application (2018-2023)

5.3.2 Global Endometriosis Price Forecast by Application (2024-2029)

6 US & Canada

6.1 US & Canada Endometriosis Market Size by Type

6.1.1 US & Canada Endometriosis Sales by Type (2018-2029)

6.1.2 US & Canada Endometriosis Revenue by Type (2018-2029)

6.2 US & Canada Endometriosis Market Size by Application

6.2.1 US & Canada Endometriosis Sales by Application (2018-2029)

6.2.2 US & Canada Endometriosis Revenue by Application (2018-2029)

6.3 US & Canada Endometriosis Market Size by Country

6.3.1 US & Canada Endometriosis Revenue by Country: 2018 VS 2022 VS 2029

6.3.2 US & Canada Endometriosis Sales by Country (2018-2029)

6.3.3 US & Canada Endometriosis Revenue by Country (2018-2029)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Endometriosis Market Size by Type

7.1.1 Europe Endometriosis Sales by Type (2018-2029)

7.1.2 Europe Endometriosis Revenue by Type (2018-2029)

7.2 Europe Endometriosis Market Size by Application

7.2.1 Europe Endometriosis Sales by Application (2018-2029)

7.2.2 Europe Endometriosis Revenue by Application (2018-2029)

7.3 Europe Endometriosis Market Size by Country

7.3.1 Europe Endometriosis Revenue by Country: 2018 VS 2022 VS 2029

7.3.2 Europe Endometriosis Sales by Country (2018-2029)

7.3.3 Europe Endometriosis Revenue by Country (2018-2029)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Endometriosis Market Size

8.1.1 China Endometriosis Sales (2018-2029)

8.1.2 China Endometriosis Revenue (2018-2029)

8.2 China Endometriosis Market Size by Application

8.2.1 China Endometriosis Sales by Application (2018-2029)

8.2.2 China Endometriosis Revenue by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Endometriosis Market Size by Type

9.1.1 Asia Endometriosis Sales by Type (2018-2029)

9.1.2 Asia Endometriosis Revenue by Type (2018-2029)

9.2 Asia Endometriosis Market Size by Application

9.2.1 Asia Endometriosis Sales by Application (2018-2029)

9.2.2 Asia Endometriosis Revenue by Application (2018-2029)

9.3 Asia Endometriosis Sales by Region

9.3.1 Asia Endometriosis Revenue by Region: 2018 VS 2022 VS 2029

9.3.2 Asia Endometriosis Revenue by Region (2018-2029)

9.3.3 Asia Endometriosis Sales by Region (2018-2029)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Endometriosis Market Size by Type

10.1.1 Middle East, Africa and Latin America Endometriosis Sales by Type (2018-2029)

10.1.2 Middle East, Africa and Latin America Endometriosis Revenue by Type (2018-2029)

10.2 Middle East, Africa and Latin America Endometriosis Market Size by Application

10.2.1 Middle East, Africa and Latin America Endometriosis Sales by Application (2018-2029)

10.2.2 Middle East, Africa and Latin America Endometriosis Revenue by Application (2018-2029)

10.3 Middle East, Africa and Latin America Endometriosis Sales by Country

10.3.1 Middle East, Africa and Latin America Endometriosis Revenue by Country: 2018 VS 2022 VS 2029

10.3.2 Middle East, Africa and Latin America Endometriosis Revenue by Country (2018-2029)

10.3.3 Middle East, Africa and Latin America Endometriosis Sales by Country (2018-2029)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 AbbVie

11.1.1 AbbVie Company Information

11.1.2 AbbVie Overview

11.1.3 AbbVie Endometriosis Sales, Price, Revenue and Gross Margin (2018-2023)

11.1.4 AbbVie Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 AbbVie Recent Developments

11.2 AstraZeneca

11.2.1 AstraZeneca Company Information

11.2.2 AstraZeneca Overview

11.2.3 AstraZeneca Endometriosis Sales, Price, Revenue and Gross Margin (2018-2023)

11.2.4 AstraZeneca Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 AstraZeneca Recent Developments

11.3 Bayer HealthCare

11.3.1 Bayer HealthCare Company Information

11.3.2 Bayer HealthCare Overview

11.3.3 Bayer HealthCare Endometriosis Sales, Price, Revenue and Gross Margin (2018-2023)

11.3.4 Bayer HealthCare Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Bayer HealthCare Recent Developments

11.4 Pfizer

11.4.1 Pfizer Company Information

11.4.2 Pfizer Overview

11.4.3 Pfizer Endometriosis Sales, Price, Revenue and Gross Margin (2018-2023)

11.4.4 Pfizer Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Pfizer Recent Developments

11.5 Addex Therapeutics

11.5.1 Addex Therapeutics Company Information

11.5.2 Addex Therapeutics Overview

11.5.3 Addex Therapeutics Endometriosis Sales, Price, Revenue and Gross Margin (2018-2023)

11.5.4 Addex Therapeutics Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Addex Therapeutics Recent Developments

11.6 Astellas Pharma

11.6.1 Astellas Pharma Company Information

11.6.2 Astellas Pharma Overview

11.6.3 Astellas Pharma Endometriosis Sales, Price, Revenue and Gross Margin (2018-2023)

11.6.4 Astellas Pharma Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Astellas Pharma Recent Developments

11.7 Debiopharm

11.7.1 Debiopharm Company Information

11.7.2 Debiopharm Overview

11.7.3 Debiopharm Endometriosis Sales, Price, Revenue and Gross Margin (2018-2023)

11.7.4 Debiopharm Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Debiopharm Recent Developments

11.8 ElexoPharm

11.8.1 ElexoPharm Company Information

11.8.2 ElexoPharm Overview

11.8.3 ElexoPharm Endometriosis Sales, Price, Revenue and Gross Margin (2018-2023)

11.8.4 ElexoPharm Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 ElexoPharm Recent Developments

11.9 EndoCeutics

11.9.1 EndoCeutics Company Information

11.9.2 EndoCeutics Overview

11.9.3 EndoCeutics Endometriosis Sales, Price, Revenue and Gross Margin (2018-2023)

11.9.4 EndoCeutics Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 EndoCeutics Recent Developments

11.10 Euroscreen

11.10.1 Euroscreen Company Information

11.10.2 Euroscreen Overview

11.10.3 Euroscreen Endometriosis Sales, Price, Revenue and Gross Margin (2018-2023)

11.10.4 Euroscreen Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Euroscreen Recent Developments

11.11 Forendo Pharma

11.11.1 Forendo Pharma Company Information

11.11.2 Forendo Pharma Overview

11.11.3 Forendo Pharma Endometriosis Sales, Price, Revenue and Gross Margin (2018-2023)

11.11.4 Forendo Pharma Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Forendo Pharma Recent Developments

11.12 Kissei Pharmaceutical

11.12.1 Kissei Pharmaceutical Company Information

11.12.2 Kissei Pharmaceutical Overview

11.12.3 Kissei Pharmaceutical Endometriosis Sales, Price, Revenue and Gross Margin (2018-2023)

11.12.4 Kissei Pharmaceutical Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Kissei Pharmaceutical Recent Developments

11.13 Neurocrine Biosciences

11.13.1 Neurocrine Biosciences Company Information

11.13.2 Neurocrine Biosciences Overview

11.13.3 Neurocrine Biosciences Endometriosis Sales, Price, Revenue and Gross Margin (2018-2023)

11.13.4 Neurocrine Biosciences Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

11.13.5 Neurocrine Biosciences Recent Developments

11.14 Nippon Shinyaku

11.14.1 Nippon Shinyaku Company Information

11.14.2 Nippon Shinyaku Overview

11.14.3 Nippon Shinyaku Endometriosis Sales, Price, Revenue and Gross Margin (2018-2023)

11.14.4 Nippon Shinyaku Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

11.14.5 Nippon Shinyaku Recent Developments

11.15 Takeda

11.15.1 Takeda Company Information

11.15.2 Takeda Overview

11.15.3 Takeda Endometriosis Sales, Price, Revenue and Gross Margin (2018-2023)

11.15.4 Takeda Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

11.15.5 Takeda Recent Developments

11.16 Bayer AG

11.16.1 Bayer AG Company Information

11.16.2 Bayer AG Overview

11.16.3 Bayer AG Endometriosis Sales, Price, Revenue and Gross Margin (2018-2023)

11.16.4 Bayer AG Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

11.16.5 Bayer AG Recent Developments

11.17 Neurocrine Biosciences

11.17.1 Neurocrine Biosciences Company Information

11.17.2 Neurocrine Biosciences Overview

11.17.3 Neurocrine Biosciences Endometriosis Sales, Price, Revenue and Gross Margin (2018-2023)

11.17.4 Neurocrine Biosciences Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

11.17.5 Neurocrine Biosciences Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Endometriosis Industry Chain Analysis

12.2 Endometriosis Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Endometriosis Production Mode & Process

12.4 Endometriosis Sales and Marketing

12.4.1 Endometriosis Sales Channels

12.4.2 Endometriosis Distributors

12.5 Endometriosis Customers

13 Market Dynamics

13.1 Endometriosis Industry Trends

13.2 Endometriosis Market Drivers

13.3 Endometriosis Market Challenges

13.4 Endometriosis Market Restraints

14 Key Findings in The Global Endometriosis Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

AbbVie

Astrazeneca plc

Bayer HealthCare

Pfizer Inc

Addex Therapeutics

Astellas Pharma

Debiopharm

ElexoPharm GmbH

EndoCeutics

Euroscreen S.A.

Forendo Pharma

Kissei Pharmaceutical

Nippon Shinyaku

Takeda

Bayer

List of Tables

Table 1. Global Endometriosis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Table 2. Major Manufacturers of Gonadotropins Releasing Hormone Agonists

Table 3. Major Manufacturers of Non-Steroidal Anti-Inflammatory Drugs

Table 4. Major Manufacturers of Progestin

Table 5. Major Manufacturers of Oral Contraceptive Pills

Table 6. Global Endometriosis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Table 7. Global Endometriosis Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Endometriosis Revenue by Region (2018-2023) & (US$ Million)

Table 9. Global Endometriosis Revenue by Region (2024-2029) & (US$ Million)

Table 10. Global Endometriosis Revenue Market Share by Region (2018-2023)

Table 11. Global Endometriosis Revenue Market Share by Region (2024-2029)

Table 12. Global Endometriosis Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 13. Global Endometriosis Sales by Region (2018-2023) & (K Units)

Table 14. Global Endometriosis Sales by Region (2024-2029) & (K Units)

Table 15. Global Endometriosis Sales Market Share by Region (2018-2023)

Table 16. Global Endometriosis Sales Market Share by Region (2024-2029)

Table 17. Global Endometriosis Sales by Manufacturers (2018-2023) & (K Units)

Table 18. Global Endometriosis Sales Share by Manufacturers (2018-2023)

Table 19. Global Endometriosis Revenue by Manufacturers (2018-2023) & (US$ Million)

Table 20. Global Endometriosis Revenue Share by Manufacturers (2018-2023)

Table 21. Global Key Players of Endometriosis, Industry Ranking, 2021 VS 2022 VS 2023

Table 22. Endometriosis Price by Manufacturers 2018-2023 (USD/Unit)

Table 23. Global Endometriosis Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 24. Global Endometriosis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometriosis as of 2022)

Table 25. Global Key Manufacturers of Endometriosis, Manufacturing Base Distribution and Headquarters

Table 26. Global Key Manufacturers of Endometriosis, Product Offered and Application

Table 27. Global Key Manufacturers of Endometriosis, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Endometriosis Sales by Type (2018-2023) & (K Units)

Table 30. Global Endometriosis Sales by Type (2024-2029) & (K Units)

Table 31. Global Endometriosis Sales Share by Type (2018-2023)

Table 32. Global Endometriosis Sales Share by Type (2024-2029)

Table 33. Global Endometriosis Revenue by Type (2018-2023) & (US$ Million)

Table 34. Global Endometriosis Revenue by Type (2024-2029) & (US$ Million)

Table 35. Global Endometriosis Revenue Share by Type (2018-2023)

Table 36. Global Endometriosis Revenue Share by Type (2024-2029)

Table 37. Endometriosis Price by Type (2018-2023) & (USD/Unit)

Table 38. Global Endometriosis Price Forecast by Type (2024-2029) & (USD/Unit)

Table 39. Global Endometriosis Sales by Application (2018-2023) & (K Units)

Table 40. Global Endometriosis Sales by Application (2024-2029) & (K Units)

Table 41. Global Endometriosis Sales Share by Application (2018-2023)

Table 42. Global Endometriosis Sales Share by Application (2024-2029)

Table 43. Global Endometriosis Revenue by Application (2018-2023) & (US$ Million)

Table 44. Global Endometriosis Revenue by Application (2024-2029) & (US$ Million)

Table 45. Global Endometriosis Revenue Share by Application (2018-2023)

Table 46. Global Endometriosis Revenue Share by Application (2024-2029)

Table 47. Endometriosis Price by Application (2018-2023) & (USD/Unit)

Table 48. Global Endometriosis Price Forecast by Application (2024-2029) & (USD/Unit)

Table 49. US & Canada Endometriosis Sales by Type (2018-2023) & (K Units)

Table 50. US & Canada Endometriosis Sales by Type (2024-2029) & (K Units)

Table 51. US & Canada Endometriosis Revenue by Type (2018-2023) & (US$ Million)

Table 52. US & Canada Endometriosis Revenue by Type (2024-2029) & (US$ Million)

Table 53. US & Canada Endometriosis Sales by Application (2018-2023) & (K Units)

Table 54. US & Canada Endometriosis Sales by Application (2024-2029) & (K Units)

Table 55. US & Canada Endometriosis Revenue by Application (2018-2023) & (US$ Million)

Table 56. US & Canada Endometriosis Revenue by Application (2024-2029) & (US$ Million)

Table 57. US & Canada Endometriosis Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 58. US & Canada Endometriosis Revenue by Country (2018-2023) & (US$ Million)

Table 59. US & Canada Endometriosis Revenue by Country (2024-2029) & (US$ Million)

Table 60. US & Canada Endometriosis Sales by Country (2018-2023) & (K Units)

Table 61. US & Canada Endometriosis Sales by Country (2024-2029) & (K Units)

Table 62. Europe Endometriosis Sales by Type (2018-2023) & (K Units)

Table 63. Europe Endometriosis Sales by Type (2024-2029) & (K Units)

Table 64. Europe Endometriosis Revenue by Type (2018-2023) & (US$ Million)

Table 65. Europe Endometriosis Revenue by Type (2024-2029) & (US$ Million)

Table 66. Europe Endometriosis Sales by Application (2018-2023) & (K Units)

Table 67. Europe Endometriosis Sales by Application (2024-2029) & (K Units)

Table 68. Europe Endometriosis Revenue by Application (2018-2023) & (US$ Million)

Table 69. Europe Endometriosis Revenue by Application (2024-2029) & (US$ Million)

Table 70. Europe Endometriosis Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 71. Europe Endometriosis Revenue by Country (2018-2023) & (US$ Million)

Table 72. Europe Endometriosis Revenue by Country (2024-2029) & (US$ Million)

Table 73. Europe Endometriosis Sales by Country (2018-2023) & (K Units)

Table 74. Europe Endometriosis Sales by Country (2024-2029) & (K Units)

Table 75. China Endometriosis Sales by Type (2018-2023) & (K Units)

Table 76. China Endometriosis Sales by Type (2024-2029) & (K Units)

Table 77. China Endometriosis Revenue by Type (2018-2023) & (US$ Million)

Table 78. China Endometriosis Revenue by Type (2024-2029) & (US$ Million)

Table 79. China Endometriosis Sales by Application (2018-2023) & (K Units)

Table 80. China Endometriosis Sales by Application (2024-2029) & (K Units)

Table 81. China Endometriosis Revenue by Application (2018-2023) & (US$ Million)

Table 82. China Endometriosis Revenue by Application (2024-2029) & (US$ Million)

Table 83. Asia Endometriosis Sales by Type (2018-2023) & (K Units)

Table 84. Asia Endometriosis Sales by Type (2024-2029) & (K Units)

Table 85. Asia Endometriosis Revenue by Type (2018-2023) & (US$ Million)

Table 86. Asia Endometriosis Revenue by Type (2024-2029) & (US$ Million)

Table 87. Asia Endometriosis Sales by Application (2018-2023) & (K Units)

Table 88. Asia Endometriosis Sales by Application (2024-2029) & (K Units)

Table 89. Asia Endometriosis Revenue by Application (2018-2023) & (US$ Million)

Table 90. Asia Endometriosis Revenue by Application (2024-2029) & (US$ Million)

Table 91. Asia Endometriosis Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 92. Asia Endometriosis Revenue by Region (2018-2023) & (US$ Million)

Table 93. Asia Endometriosis Revenue by Region (2024-2029) & (US$ Million)

Table 94. Asia Endometriosis Sales by Region (2018-2023) & (K Units)

Table 95. Asia Endometriosis Sales by Region (2024-2029) & (K Units)

Table 96. Middle East, Africa and Latin America Endometriosis Sales by Type (2018-2023) & (K Units)

Table 97. Middle East, Africa and Latin America Endometriosis Sales by Type (2024-2029) & (K Units)

Table 98. Middle East, Africa and Latin America Endometriosis Revenue by Type (2018-2023) & (US$ Million)

Table 99. Middle East, Africa and Latin America Endometriosis Revenue by Type (2024-2029) & (US$ Million)

Table 100. Middle East, Africa and Latin America Endometriosis Sales by Application (2018-2023) & (K Units)

Table 101. Middle East, Africa and Latin America Endometriosis Sales by Application (2024-2029) & (K Units)

Table 102. Middle East, Africa and Latin America Endometriosis Revenue by Application (2018-2023) & (US$ Million)

Table 103. Middle East, Africa and Latin America Endometriosis Revenue by Application (2024-2029) & (US$ Million)

Table 104. Middle East, Africa and Latin America Endometriosis Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 105. Middle East, Africa and Latin America Endometriosis Revenue by Country (2018-2023) & (US$ Million)

Table 106. Middle East, Africa and Latin America Endometriosis Revenue by Country (2024-2029) & (US$ Million)

Table 107. Middle East, Africa and Latin America Endometriosis Sales by Country (2018-2023) & (K Units)

Table 108. Middle East, Africa and Latin America Endometriosis Sales by Country (2024-2029) & (K Units)

Table 109. AbbVie Company Information

Table 110. AbbVie Description and Major Businesses

Table 111. AbbVie Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 112. AbbVie Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

Table 113. AbbVie Recent Developments

Table 114. AstraZeneca Company Information

Table 115. AstraZeneca Description and Major Businesses

Table 116. AstraZeneca Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 117. AstraZeneca Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. AstraZeneca Recent Developments

Table 119. Bayer HealthCare Company Information

Table 120. Bayer HealthCare Description and Major Businesses

Table 121. Bayer HealthCare Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 122. Bayer HealthCare Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

Table 123. Bayer HealthCare Recent Developments

Table 124. Pfizer Company Information

Table 125. Pfizer Description and Major Businesses

Table 126. Pfizer Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 127. Pfizer Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

Table 128. Pfizer Recent Developments

Table 129. Addex Therapeutics Company Information

Table 130. Addex Therapeutics Description and Major Businesses

Table 131. Addex Therapeutics Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 132. Addex Therapeutics Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

Table 133. Addex Therapeutics Recent Developments

Table 134. Astellas Pharma Company Information

Table 135. Astellas Pharma Description and Major Businesses

Table 136. Astellas Pharma Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 137. Astellas Pharma Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

Table 138. Astellas Pharma Recent Developments

Table 139. Debiopharm Company Information

Table 140. Debiopharm Description and Major Businesses

Table 141. Debiopharm Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 142. Debiopharm Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

Table 143. Debiopharm Recent Developments

Table 144. ElexoPharm Company Information

Table 145. ElexoPharm Description and Major Businesses

Table 146. ElexoPharm Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 147. ElexoPharm Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

Table 148. ElexoPharm Recent Developments

Table 149. EndoCeutics Company Information

Table 150. EndoCeutics Description and Major Businesses

Table 151. EndoCeutics Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 152. EndoCeutics Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

Table 153. EndoCeutics Recent Developments

Table 154. Euroscreen Company Information

Table 155. Euroscreen Description and Major Businesses

Table 156. Euroscreen Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 157. Euroscreen Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

Table 158. Euroscreen Recent Developments

Table 159. Forendo Pharma Company Information

Table 160. Forendo Pharma Description and Major Businesses

Table 161. Forendo Pharma Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 162. Forendo Pharma Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

Table 163. Forendo Pharma Recent Developments

Table 164. Kissei Pharmaceutical Company Information

Table 165. Kissei Pharmaceutical Description and Major Businesses

Table 166. Kissei Pharmaceutical Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 167. Kissei Pharmaceutical Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

Table 168. Kissei Pharmaceutical Recent Developments

Table 169. Neurocrine Biosciences Company Information

Table 170. Neurocrine Biosciences Description and Major Businesses

Table 171. Neurocrine Biosciences Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 172. Neurocrine Biosciences Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

Table 173. Neurocrine Biosciences Recent Developments

Table 174. Nippon Shinyaku Company Information

Table 175. Nippon Shinyaku Description and Major Businesses

Table 176. Nippon Shinyaku Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 177. Nippon Shinyaku Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

Table 178. Nippon Shinyaku Recent Developments

Table 179. Takeda Company Information

Table 180. Takeda Description and Major Businesses

Table 181. Takeda Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 182. Takeda Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

Table 183. Takeda Recent Developments

Table 184. Bayer AG Company Information

Table 185. Bayer AG Description and Major Businesses

Table 186. Bayer AG Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 187. Bayer AG Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

Table 188. Bayer AG Recent Developments

Table 189. Neurocrine Biosciences Company Information

Table 190. Neurocrine Biosciences Description and Major Businesses

Table 191. Neurocrine Biosciences Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 192. Neurocrine Biosciences Endometriosis Product Model Numbers, Pictures, Descriptions and Specifications

Table 193. Neurocrine Biosciences Recent Developments

Table 194. Key Raw Materials Lists

Table 195. Raw Materials Key Suppliers Lists

Table 196. Endometriosis Distributors List

Table 197. Endometriosis Customers List

Table 198. Endometriosis Market Trends

Table 199. Endometriosis Market Drivers

Table 200. Endometriosis Market Challenges

Table 201. Endometriosis Market Restraints

Table 202. Research Programs/Design for This Report

Table 203. Key Data Information from Secondary Sources

Table 204. Key Data Information from Primary Sources

List of Figures

Figure 1. Endometriosis Product Picture

Figure 2. Global Endometriosis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Endometriosis Market Share by Type in 2022 & 2029

Figure 4. Gonadotropins Releasing Hormone Agonists Product Picture

Figure 5. Non-Steroidal Anti-Inflammatory Drugs Product Picture

Figure 6. Progestin Product Picture

Figure 7. Oral Contraceptive Pills Product Picture

Figure 8. Global Endometriosis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 9. Global Endometriosis Market Share by Application in 2022 & 2029

Figure 10. Hospital Use

Figure 11. Clinic Use

Figure 12. Other

Figure 13. Endometriosis Report Years Considered

Figure 14. Global Endometriosis Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 15. Global Endometriosis Revenue 2018-2029 (US$ Million)

Figure 16. Global Endometriosis Revenue Market Share by Region in Percentage: 2022 Versus 2029

Figure 17. Global Endometriosis Revenue Market Share by Region (2018-2029)

Figure 18. Global Endometriosis Sales 2018-2029 ((K Units)

Figure 19. Global Endometriosis Sales Market Share by Region (2018-2029)

Figure 20. US & Canada Endometriosis Sales YoY (2018-2029) & (K Units)

Figure 21. US & Canada Endometriosis Revenue YoY (2018-2029) & (US$ Million)

Figure 22. Europe Endometriosis Sales YoY (2018-2029) & (K Units)

Figure 23. Europe Endometriosis Revenue YoY (2018-2029) & (US$ Million)

Figure 24. China Endometriosis Sales YoY (2018-2029) & (K Units)

Figure 25. China Endometriosis Revenue YoY (2018-2029) & (US$ Million)

Figure 26. Asia (excluding China) Endometriosis Sales YoY (2018-2029) & (K Units)

Figure 27. Asia (excluding China) Endometriosis Revenue YoY (2018-2029) & (US$ Million)

Figure 28. Middle East, Africa and Latin America Endometriosis Sales YoY (2018-2029) & (K Units)

Figure 29. Middle East, Africa and Latin America Endometriosis Revenue YoY (2018-2029) & (US$ Million)

Figure 30. The Endometriosis Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022

Figure 31. The Top 5 and 10 Largest Manufacturers of Endometriosis in the World: Market Share by Endometriosis Revenue in 2022

Figure 32. Global Endometriosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 33. Global Endometriosis Sales Market Share by Type (2018-2029)

Figure 34. Global Endometriosis Revenue Market Share by Type (2018-2029)

Figure 35. Global Endometriosis Sales Market Share by Application (2018-2029)

Figure 36. Global Endometriosis Revenue Market Share by Application (2018-2029)

Figure 37. US & Canada Endometriosis Sales Market Share by Type (2018-2029)

Figure 38. US & Canada Endometriosis Revenue Market Share by Type (2018-2029)

Figure 39. US & Canada Endometriosis Sales Market Share by Application (2018-2029)

Figure 40. US & Canada Endometriosis Revenue Market Share by Application (2018-2029)

Figure 41. US & Canada Endometriosis Revenue Share by Country (2018-2029)

Figure 42. US & Canada Endometriosis Sales Share by Country (2018-2029)

Figure 43. U.S. Endometriosis Revenue (2018-2029) & (US$ Million)

Figure 44. Canada Endometriosis Revenue (2018-2029) & (US$ Million)

Figure 45. Europe Endometriosis Sales Market Share by Type (2018-2029)

Figure 46. Europe Endometriosis Revenue Market Share by Type (2018-2029)

Figure 47. Europe Endometriosis Sales Market Share by Application (2018-2029)

Figure 48. Europe Endometriosis Revenue Market Share by Application (2018-2029)

Figure 49. Europe Endometriosis Revenue Share by Country (2018-2029)

Figure 50. Europe Endometriosis Sales Share by Country (2018-2029)

Figure 51. Germany Endometriosis Revenue (2018-2029) & (US$ Million)

Figure 52. France Endometriosis Revenue (2018-2029) & (US$ Million)

Figure 53. U.K. Endometriosis Revenue (2018-2029) & (US$ Million)

Figure 54. Italy Endometriosis Revenue (2018-2029) & (US$ Million)

Figure 55. Russia Endometriosis Revenue (2018-2029) & (US$ Million)

Figure 56. China Endometriosis Sales Market Share by Type (2018-2029)

Figure 57. China Endometriosis Revenue Market Share by Type (2018-2029)

Figure 58. China Endometriosis Sales Market Share by Application (2018-2029)

Figure 59. China Endometriosis Revenue Market Share by Application (2018-2029)

Figure 60. Asia Endometriosis Sales Market Share by Type (2018-2029)

Figure 61. Asia Endometriosis Revenue Market Share by Type (2018-2029)

Figure 62. Asia Endometriosis Sales Market Share by Application (2018-2029)

Figure 63. Asia Endometriosis Revenue Market Share by Application (2018-2029)

Figure 64. Asia Endometriosis Revenue Share by Region (2018-2029)

Figure 65. Asia Endometriosis Sales Share by Region (2018-2029)

Figure 66. Japan Endometriosis Revenue (2018-2029) & (US$ Million)

Figure 67. South Korea Endometriosis Revenue (2018-2029) & (US$ Million)

Figure 68. China Taiwan Endometriosis Revenue (2018-2029) & (US$ Million)

Figure 69. Southeast Asia Endometriosis Revenue (2018-2029) & (US$ Million)

Figure 70. India Endometriosis Revenue (2018-2029) & (US$ Million)

Figure 71. Middle East, Africa and Latin America Endometriosis Sales Market Share by Type (2018-2029)

Figure 72. Middle East, Africa and Latin America Endometriosis Revenue Market Share by Type (2018-2029)

Figure 73. Middle East, Africa and Latin America Endometriosis Sales Market Share by Application (2018-2029)

Figure 74. Middle East, Africa and Latin America Endometriosis Revenue Market Share by Application (2018-2029)

Figure 75. Middle East, Africa and Latin America Endometriosis Revenue Share by Country (2018-2029)

Figure 76. Middle East, Africa and Latin America Endometriosis Sales Share by Country (2018-2029)

Figure 77. Brazil Endometriosis Revenue (2018-2029) & (US$ Million)

Figure 78. Mexico Endometriosis Revenue (2018-2029) & (US$ Million)

Figure 79. Turkey Endometriosis Revenue (2018-2029) & (US$ Million)

Figure 80. Israel Endometriosis Revenue (2018-2029) & (US$ Million)

Figure 81. GCC Countries Endometriosis Revenue (2018-2029) & (US$ Million)

Figure 82. Endometriosis Value Chain

Figure 83. Endometriosis Production Process

Figure 84. Channels of Distribution

Figure 85. Distributors Profiles

Figure 86. Bottom-up and Top-down Approaches for This Report

Figure 87. Data Triangulation

Figure 88. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions